Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003 - Wikidata - wikimedia - TriplyDB

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

http://www.wikidata.org/entity/Q24792023

about

World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010

P2860

Q28597168-E403DD6C-C8C8-44C7-8C5D-C4D0788078C3 Q51754688-4ADD463F-C003-40B3-BA57-CD0E3B5FB460 Q54417681-998F2B09-8365-4DB0-BD48-CA6F299B7552 Q56909843-CD7856DC-34B8-41B6-A0E6-63A995AF595D

P2860

Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003

http://www.wikidata.org/entity/Q24792023

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Tracking the implementation of ...... ed States during 2002 and 2003

@ast

Tracking the implementation of ...... ed States during 2002 and 2003

@en

Tracking the implementation of ...... ed States during 2002 and 2003

@nl

type

label

Tracking the implementation of ...... ed States during 2002 and 2003

@ast

Tracking the implementation of ...... ed States during 2002 and 2003

@en

Tracking the implementation of ...... ed States during 2002 and 2003

@nl

prefLabel

Tracking the implementation of ...... ed States during 2002 and 2003

@ast

Tracking the implementation of ...... ed States during 2002 and 2003

@en

Tracking the implementation of ...... ed States during 2002 and 2003

@nl

P1433

Q24792023-1B4ED19A-B370-49D0-873C-CB4C1344C84D

P1476

Q24792023-5B479FC8-36B8-4AEC-A3D7-D491BFF25A97

P2093

Q24792023-43D611D7-20BA-40C1-8F81-92FC4C1FC7F4

Q24792023-6C9FA989-CFC2-4D89-B9D4-D9C3455B7AD7

Q24792023-7A4C5A5D-1013-4511-9199-0FFF3A5156BA

Q24792023-9F117380-6406-4733-9092-C9C385205B1F

Q24792023-EE039E95-46B0-4984-84B3-36B30EFA3B26

Q24792023-EFA58C0F-7720-449D-82D1-75455FDAB5A6

P2860

Q24792023-AC517CC1-15D2-493B-87CD-BD8E37413B1A

Q24792023-C4E800CF-1209-4635-BB3C-9E5587186011

Q24792023-DBD4804A-B55E-48B8-855D-77AC7B1600FE

P2888

Q24792023-64C21EC0-1A11-4B2C-8E7F-2FA703BAB387

P304

Q24792023-D71F1976-4EC3-42A6-A779-705BC732F63C

P31

Q24792023-F89AEDBD-CF76-43BB-BE58-5B2B51CC9182

P3181

Q24792023-4D204068-31F6-46C3-BCEF-84959AC71FFA

P356

Q24792023-D7050952-0D9F-4323-B892-E391EB84BEEF

P407

Q24792023-9E5E7BD3-9B31-4677-8EA0-DEBE1FF1BC30

P433

Q24792023-6404DA42-8078-4C30-A5BF-E540B7AC09C1

P478

Q24792023-1915DC53-1867-48D2-A112-9CDE26C3867D

P577

Q24792023-B4F2931A-5C81-4956-8A77-FBF760836B0F

P5875

Q24792023-2DE0A633-88B2-43C3-A2CD-423F072DCC35

P6179

Q24792023-7820FCE2-31A6-4537-905B-EF20588DC1EC

P698

Q24792023-FF761957-77F2-40A5-96E6-D5D3753E32AE

P932

Q24792023-A2AD2D12-4EDC-4AEC-8779-1B607B71A443

P3181

P356

P1433

Annals of Clinical Microbiology and Antimicrobials

P1476

Tracking the implementation of ...... ed States during 2002 and 2003

@en

P2093

Clyde Thornsberry

http://www.w3.org/2001/XMLSchema#string

Daniel F Sahm

http://www.w3.org/2001/XMLSchema#string

Deborah C Draghi

http://www.w3.org/2001/XMLSchema#string

James A Karlowsky

http://www.w3.org/2001/XMLSchema#string

Mark E Jones

http://www.w3.org/2001/XMLSchema#string

Ronald N Master

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001)

In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.

Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

480646

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-0711-3-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8928048

http://www.w3.org/2001/XMLSchema#string

P6179

1039221572

http://www.w3.org/2001/XMLSchema#string

P698

14713319

http://www.w3.org/2001/XMLSchema#string

P932

324563

http://www.w3.org/2001/XMLSchema#string